The method, published in the journal Nature Communications, has been biologically tested in breast, prostate, lung and colon cancer cell lines, as well as retrospective analysis of survival of thousands of patients.
iPC will focus on identifying effective personalised medicine methodologies for paediatric cancers, addressing a multitude of challenges using computational resources .
